Overall rank by patents
#29,030
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS).
The verdict
IGM holds 9 US patents across 11 technology areas, rank #29,030 of 50,000 tracked assignees.
IGM Resins Italia S.r.l. has been granted 9 US utility patents between 2016 and 2024, placing IGM Resins Italia S.r.l. at rank #29,030 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS). As a Foreign Corporation, IGM Resins Italia S.r.l. is one of the more focused assignees in the PatentsView dataset. By volume, IGM sits between ID Pharma Co., Ltd. (9 patents, rank #29,026) and Imaginalis S.r.l. (9 patents, rank #29,034) - the closest US assignees by grant volume. The composite Innovation Score of 48.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. IGM Resins Italia S.r.l.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark IGM Resins Italia S.r.l. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ID Pharma Co., Ltd.
9 patents
IDM GLOBAL, INC.
9 patents
IDSC Holdings LLC
9 patents
IFCO SYSTEMS GMBH
9 patents
IHARA SCIENCE CORPORATION
9 patents
II-VI ADVANCED MATERIALS, LLC
9 patents
ILJIN ELECTRIC CO., LTD.
9 patents
IMAGINALIS S.R.L.
9 patents
IGM RESINS ITALIA S.R.L.
9 patents
What this shows IGM holds 9 patents at rank #29,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,030 in granted patent volume.
Other assignees with the most granted patents in IGM's primary technology class.
IGM's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 11.1% |
| 2017 | 1 | 11.1% |
| 2018 | 2 | 22.2% |
| 2022 | 2 | 22.2% |
| 2023 | 2 | 22.2% |
| 2024 | 1 | 11.1% |
Top 11 of 11 technology areas
Overall rank by patents
#29,030
Across all tracked assignees
48.4 out of 100
How to use this portfolio
IGM's 9 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.